Literature DB >> 10219829

Bisphosphonates and gastrointestinal damage.

M A Blank, G W Gibson, R J Phipps, P N Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10219829     DOI: 10.1023/a:1026657724424

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  7 in total

1.  Incidence of gastrointestinal side effects due to alendronate is high in clinical practice.

Authors:  R Kelly; H Taggart
Journal:  BMJ       Date:  1997-11-08

2.  Comparative study of potential for bisphosphonates to damage gastric mucosa of rats.

Authors:  C P Peter; M V Kindt; J A Majka
Journal:  Dig Dis Sci       Date:  1998-05       Impact factor: 3.199

3.  Nonclinical model for assessing gastric effects of bisphosphonates.

Authors:  M A Blank; B L Ems; G W Gibson; W R Myers; S K Berman; R J Phipps; P N Smith
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

4.  Alendronate induces gastric injury and delays ulcer healing in rodents.

Authors:  S N Elliott; W McKnight; N M Davies; W K MacNaughton; J L Wallace
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

5.  Upper gastrointestinal adverse events and cyclical etidronate.

Authors:  T van Staa; L Abenhaim; C Cooper
Journal:  Am J Med       Date:  1997-12       Impact factor: 4.965

6.  Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis.

Authors:  J R Tucci; R P Tonino; R D Emkey; C A Peverly; U Kher; A C Santora
Journal:  Am J Med       Date:  1996-11       Impact factor: 4.965

7.  Effects of alendronate on gastric and duodenal mucosa.

Authors:  F Lanza; M F Rack; T J Simon; A Lombardi; R Reyes; S Suryawanshi
Journal:  Am J Gastroenterol       Date:  1998-05       Impact factor: 10.864

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.